Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Recombinant Coagulation Factor VIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn Excision and Grafting

NCT00243243 is registered in ClinicalTrials.gov with United States Army Institute of Surgical Research as lead sponsor.

NCT NCT00243243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00243243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Recombinant Coagulation Factor VIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn Excision and Grafting
Lead sponsor
United States Army Institute of Surgical Research
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2006
Completion date
July 31, 2011
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

burns